What you should know:
1. CRH’s operating income was $3.8 million, with a 13 percent operating income margin.
2. The company’s adjusted operating EBITDA was $13.1 million, with a 45 percent adjusted operating EBITDA margin.
3. CRH saw 77,501 anesthesia patients during the quarter.
4. The company posted a net loss of $100,000 attributed to shareholders.
5. CRH’s adjusted operating EBITDA attributable to shareholders was $8.8 million.
6. The company’s net cash provided by operating activities was $12.4 million.
CRH CEO Tushar Ramani, MD, said, “CRH is well positioned to grow its current model, expand its offerings and continue to deliver strong financial results.” CRH appointed Dr. Ramani CEO April 9.
More articles on surgery centers:
Michigan Medicine center adds total knee, hip replacement surgeries
First navigated reverse outpatient total shoulder procedure performed at Atlantic Coast Surgical Suites
ASCs among factors driving $1.7B growth in global arthroscopy, sports medicine markets
